APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mumps Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mumps Drug Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchMumps Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Mumps Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Mumps Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mumps Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mumps Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mumps Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mumps Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mumps Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mumps Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mumps Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mumps Drug include GlaxoSmithKline Plc, Beijing Tiantan Biological Products Co., Ltd., Beijing Minhai Biotechnology Co., Ltd, Zydus Cadila Healthcare Limited, Sinovac Biotech Ltd., Prometheon Pharma, LLC, Organic Vaccines and China National Pharmaceutical Group Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mumps Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mumps Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Mumps Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mumps Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mumps Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mumps Drug sales, projected growth trends, production technology, application and end-user industry.

Mumps Drug Segment by Company

GlaxoSmithKline Plc

Beijing Tiantan Biological Products Co., Ltd.

Beijing Minhai Biotechnology Co., Ltd

Zydus Cadila Healthcare Limited

Sinovac Biotech Ltd.

Prometheon Pharma, LLC

Organic Vaccines

China National Pharmaceutical Group Corporation

Mumps Drug Segment by Type

RIT 4385

Wistar RA 27/3

Schwarz

Others

Mumps Drug Segment by Application

Hospital

Clinic

Others

Mumps Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mumps Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mumps Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mumps Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mumps Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mumps Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mumps Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mumps Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RIT 4385 Major Manufacturers Table 3. Wistar RA 27/3 Major Manufacturers Table 4. Schwarz Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Mumps Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Mumps Drug Industry Trends Table 11. Mumps Drug Industry Drivers Table 12. Mumps Drug Industry Opportunities and Challenges Table 13. Mumps Drug Industry Restraints Table 14. Global Mumps Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Mumps Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Mumps Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Mumps Drug Revenue Market Share by Region (2021-2026) Table 18. Global Mumps Drug Revenue Market Share by Region (2027-2032) Table 19. Global Mumps Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Mumps Drug Sales by Region (2021-2026) & (W Units) Table 21. Global Mumps Drug Sales by Region (2027-2032) & (W Units) Table 22. Global Mumps Drug Sales Market Share by Region (2021-2026) Table 23. Global Mumps Drug Sales Market Share by Region (2027-2032) Table 24. Global Mumps Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Mumps Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Mumps Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Mumps Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Mumps Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Mumps Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Mumps Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Mumps Drug Manufacturers, Product Type & Application Table 32. Global Mumps Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Mumps Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Mumps Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Mumps Drug Revenue Market Share by Type (2021-2026) Table 39. Global Mumps Drug Revenue Market Share by Type (2027-2032) Table 40. Global Mumps Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Mumps Drug Sales by Type (2021-2026) & (W Units) Table 42. Global Mumps Drug Sales by Type (2027-2032) & (W Units) Table 43. Global Mumps Drug Sales Market Share by Type (2021-2026) Table 44. Global Mumps Drug Sales Market Share by Type (2027-2032) Table 45. Global Mumps Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Mumps Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Mumps Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Mumps Drug Revenue Market Share by Application (2021-2026) Table 51. Global Mumps Drug Revenue Market Share by Application (2027-2032) Table 52. Global Mumps Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Mumps Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Mumps Drug Sales by Application (2027-2032) & (W Units) Table 55. Global Mumps Drug Sales Market Share by Application (2021-2026) Table 56. Global Mumps Drug Sales Market Share by Application (2027-2032) Table 57. Global Mumps Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Mumps Drug Price by Application (2027-2032) & (US$/Unit) Table 59. GlaxoSmithKline Plc Company Information Table 60. GlaxoSmithKline Plc Business Overview Table 61. GlaxoSmithKline Plc Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. GlaxoSmithKline Plc Mumps Drug Product Portfolio Table 63. GlaxoSmithKline Plc Recent Development Table 64. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 65. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 66. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolio Table 68. Beijing Tiantan Biological Products Co., Ltd. Recent Development Table 69. Beijing Minhai Biotechnology Co., Ltd Company Information Table 70. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 71. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolio Table 73. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 74. Zydus Cadila Healthcare Limited Company Information Table 75. Zydus Cadila Healthcare Limited Business Overview Table 76. Zydus Cadila Healthcare Limited Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zydus Cadila Healthcare Limited Mumps Drug Product Portfolio Table 78. Zydus Cadila Healthcare Limited Recent Development Table 79. Sinovac Biotech Ltd. Company Information Table 80. Sinovac Biotech Ltd. Business Overview Table 81. Sinovac Biotech Ltd. Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sinovac Biotech Ltd. Mumps Drug Product Portfolio Table 83. Sinovac Biotech Ltd. Recent Development Table 84. Prometheon Pharma, LLC Company Information Table 85. Prometheon Pharma, LLC Business Overview Table 86. Prometheon Pharma, LLC Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Prometheon Pharma, LLC Mumps Drug Product Portfolio Table 88. Prometheon Pharma, LLC Recent Development Table 89. Organic Vaccines Company Information Table 90. Organic Vaccines Business Overview Table 91. Organic Vaccines Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Organic Vaccines Mumps Drug Product Portfolio Table 93. Organic Vaccines Recent Development Table 94. China National Pharmaceutical Group Corporation Company Information Table 95. China National Pharmaceutical Group Corporation Business Overview Table 96. China National Pharmaceutical Group Corporation Mumps Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. China National Pharmaceutical Group Corporation Mumps Drug Product Portfolio Table 98. China National Pharmaceutical Group Corporation Recent Development Table 99. North America Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Mumps Drug Sales by Type (2021-2026) & (W Units) Table 102. North America Mumps Drug Sales by Type (2027-2032) & (W Units) Table 103. North America Mumps Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Mumps Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Mumps Drug Sales by Application (2021-2026) & (W Units) Table 108. North America Mumps Drug Sales by Application (2027-2032) & (W Units) Table 109. North America Mumps Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Mumps Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Mumps Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Mumps Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Mumps Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 115. North America Mumps Drug Sales by Country (2021-2026) & (W Units) Table 116. North America Mumps Drug Sales by Country (2027-2032) & (W Units) Table 117. North America Mumps Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Mumps Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Mumps Drug Revenue (2021-2032) & (US$ Million) Table 120. Canada Mumps Drug Revenue (2021-2032) & (US$ Million) Table 121. Mexico Mumps Drug Revenue (2021-2032) & (US$ Million) Table 122. Europe Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Mumps Drug Sales by Type (2021-2026) & (W Units) Table 125. Europe Mumps Drug Sales by Type (2027-2032) & (W Units) Table 126. Europe Mumps Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Mumps Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Mumps Drug Sales by Application (2021-2026) & (W Units) Table 131. Europe Mumps Drug Sales by Application (2027-2032) & (W Units) Table 132. Europe Mumps Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Mumps Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Mumps Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Mumps Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Mumps Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 138. Europe Mumps Drug Sales by Country (2021-2026) & (W Units) Table 139. Europe Mumps Drug Sales by Country (2027-2032) & (W Units) Table 140. Europe Mumps Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Mumps Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Mumps Drug Revenue (2021-2032) & (US$ Million) Table 143. France Mumps Drug Revenue (2021-2032) & (US$ Million) Table 144. U.K. Mumps Drug Revenue (2021-2032) & (US$ Million) Table 145. Italy Mumps Drug Revenue (2021-2032) & (US$ Million) Table 146. Russia Mumps Drug Revenue (2021-2032) & (US$ Million) Table 147. Spain Mumps Drug Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Mumps Drug Revenue (2021-2032) & (US$ Million) Table 149. Switzerland Mumps Drug Revenue (2021-2032) & (US$ Million) Table 150. Sweden Mumps Drug Revenue (2021-2032) & (US$ Million) Table 151. Poland Mumps Drug Revenue (2021-2032) & (US$ Million) Table 152. China Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 153. China Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 154. China Mumps Drug Sales by Type (2021-2026) & (W Units) Table 155. China Mumps Drug Sales by Type (2027-2032) & (W Units) Table 156. China Mumps Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Mumps Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 159. China Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 160. China Mumps Drug Sales by Application (2021-2026) & (W Units) Table 161. China Mumps Drug Sales by Application (2027-2032) & (W Units) Table 162. China Mumps Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Mumps Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Mumps Drug Sales by Type (2021-2026) & (W Units) Table 167. Asia Mumps Drug Sales by Type (2027-2032) & (W Units) Table 168. Asia Mumps Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Mumps Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Mumps Drug Sales by Application (2021-2026) & (W Units) Table 173. Asia Mumps Drug Sales by Application (2027-2032) & (W Units) Table 174. Asia Mumps Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Mumps Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Mumps Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Mumps Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Mumps Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 180. Asia Mumps Drug Sales by Country (2021-2026) & (W Units) Table 181. Asia Mumps Drug Sales by Country (2027-2032) & (W Units) Table 182. Asia Mumps Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Mumps Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Mumps Drug Revenue (2021-2032) & (US$ Million) Table 185. South Korea Mumps Drug Revenue (2021-2032) & (US$ Million) Table 186. India Mumps Drug Revenue (2021-2032) & (US$ Million) Table 187. Australia Mumps Drug Revenue (2021-2032) & (US$ Million) Table 188. Taiwan Mumps Drug Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Mumps Drug Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Mumps Drug Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Mumps Drug Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Mumps Drug Sales by Type (2021-2026) & (W Units) Table 193. SAMEA Mumps Drug Sales by Type (2027-2032) & (W Units) Table 194. SAMEA Mumps Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Mumps Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Mumps Drug Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Mumps Drug Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Mumps Drug Sales by Application (2021-2026) & (W Units) Table 199. SAMEA Mumps Drug Sales by Application (2027-2032) & (W Units) Table 200. SAMEA Mumps Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Mumps Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Mumps Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Mumps Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Mumps Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 206. SAMEA Mumps Drug Sales by Country (2021-2026) & (W Units) Table 207. SAMEA Mumps Drug Sales by Country (2027-2032) & (W Units) Table 208. SAMEA Mumps Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Mumps Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Mumps Drug Revenue (2021-2032) & (US$ Million) Table 211. Argentina Mumps Drug Revenue (2021-2032) & (US$ Million) Table 212. Chile Mumps Drug Revenue (2021-2032) & (US$ Million) Table 213. Colombia Mumps Drug Revenue (2021-2032) & (US$ Million) Table 214. Peru Mumps Drug Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Mumps Drug Revenue (2021-2032) & (US$ Million) Table 216. Israel Mumps Drug Revenue (2021-2032) & (US$ Million) Table 217. UAE Mumps Drug Revenue (2021-2032) & (US$ Million) Table 218. Turkey Mumps Drug Revenue (2021-2032) & (US$ Million) Table 219. Iran Mumps Drug Revenue (2021-2032) & (US$ Million) Table 220. Egypt Mumps Drug Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Mumps Drug Distributors List Table 224. Mumps Drug Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Mumps Drug Image Figure 2. Global Mumps Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mumps Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. RIT 4385 Image Figure 5. Wistar RA 27/3 Image Figure 6. Schwarz Image Figure 7. Others Image Figure 8. Global Mumps Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Mumps Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Mumps Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Mumps Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Mumps Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Mumps Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Mumps Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Mumps Drug Sales (2021-2032) & (W Units) Figure 19. Global Mumps Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Mumps Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Mumps Drug Sales YoY (2021-2032) & (W Units) Figure 22. Europe Mumps Drug Sales YoY (2021-2032) & (W Units) Figure 23. China Mumps Drug Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Mumps Drug Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Mumps Drug Sales YoY (2021-2032) & (W Units) Figure 26. Global Mumps Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Mumps Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Mumps Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Mumps Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Mumps Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Mumps Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Mumps Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Mumps Drug Sales Market Share by Type (2021-2032) Figure 35. Global Mumps Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Mumps Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Mumps Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Mumps Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Mumps Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Mumps Drug Sales Market Share by Application (2021-2032) Figure 41. North America Mumps Drug Revenue Share by Type (2021-2032) Figure 42. North America Mumps Drug Sales Share by Type (2021-2032) Figure 43. North America Mumps Drug Revenue Share by Application (2021-2032) Figure 44. North America Mumps Drug Sales Share by Application (2021-2032) Figure 45. North America Mumps Drug Revenue Share by Country (2021-2032) Figure 46. North America Mumps Drug Sales Share by Country (2021-2032) Figure 47. Europe Mumps Drug Revenue Share by Type (2021-2032) Figure 48. Europe Mumps Drug Sales Share by Type (2021-2032) Figure 49. Europe Mumps Drug Revenue Share by Application (2021-2032) Figure 50. Europe Mumps Drug Sales Share by Application (2021-2032) Figure 51. Europe Mumps Drug Revenue Share by Country (2021-2032) Figure 52. Europe Mumps Drug Sales Share by Country (2021-2032) Figure 53. China Mumps Drug Revenue Share by Type (2021-2032) Figure 54. China Mumps Drug Sales Share by Type (2021-2032) Figure 55. China Mumps Drug Revenue Share by Application (2021-2032) Figure 56. China Mumps Drug Sales Share by Application (2021-2032) Figure 57. Asia Mumps Drug Revenue Share by Type (2021-2032) Figure 58. Asia Mumps Drug Sales Share by Type (2021-2032) Figure 59. Asia Mumps Drug Revenue Share by Application (2021-2032) Figure 60. Asia Mumps Drug Sales Share by Application (2021-2032) Figure 61. Asia Mumps Drug Revenue Share by Country (2021-2032) Figure 62. Asia Mumps Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Mumps Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Mumps Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Mumps Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Mumps Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Mumps Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Mumps Drug Sales Share by Country (2021-2032) Figure 69. Mumps Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Mumps Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • RIT 4385
  • Wistar RA 27/3
  • Schwarz
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • GlaxoSmithKline Plc
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Minhai Biotechnology Co., Ltd
  • Zydus Cadila Healthcare Limited
  • Sinovac Biotech Ltd.
  • Prometheon Pharma, LLC
  • Organic Vaccines
  • China National Pharmaceutical Group Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mumps Drug Market by Type
  3. 1.2.1 Global Mumps Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RIT 4385
  5. 1.2.3 Wistar RA 27/3
  6. 1.2.4 Schwarz
  7. 1.2.5 Others
  8. 1.3 Mumps Drug Market by Application
  9. 1.3.1 Global Mumps Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Mumps Drug Market Dynamics
  1. 2.1 Mumps Drug Industry Trends
  2. 2.2 Mumps Drug Industry Drivers
  3. 2.3 Mumps Drug Industry Opportunities and Challenges
  4. 2.4 Mumps Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mumps Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mumps Drug Revenue by Region
  3. 3.2.1 Global Mumps Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mumps Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Mumps Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Mumps Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mumps Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mumps Drug Sales by Region
  9. 3.4.1 Global Mumps Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mumps Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Mumps Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Mumps Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mumps Drug Revenue by Manufacturers
  2. 4.1.1 Global Mumps Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mumps Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mumps Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mumps Drug Sales by Manufacturers
  6. 4.2.1 Global Mumps Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mumps Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mumps Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mumps Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mumps Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mumps Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mumps Drug Manufacturers, Product Type & Application
  13. 4.7 Global Mumps Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mumps Drug Market CR5 and HHI
  16. 4.8.2 2025 Mumps Drug Tier 1, Tier 2, and Tier 3
5 Mumps Drug Market by Type
  1. 5.1 Global Mumps Drug Revenue by Type
  2. 5.1.1 Global Mumps Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mumps Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mumps Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mumps Drug Sales by Type
  6. 5.2.1 Global Mumps Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mumps Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Mumps Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mumps Drug Price by Type
6 Mumps Drug Market by Application
  1. 6.1 Global Mumps Drug Revenue by Application
  2. 6.1.1 Global Mumps Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mumps Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mumps Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mumps Drug Sales by Application
  6. 6.2.1 Global Mumps Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mumps Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Mumps Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mumps Drug Price by Application
7 Company Profiles
  1. 7.1 GlaxoSmithKline Plc
  2. 7.1.1 GlaxoSmithKline Plc Company Information
  3. 7.1.2 GlaxoSmithKline Plc Business Overview
  4. 7.1.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GlaxoSmithKline Plc Mumps Drug Product Portfolio
  6. 7.1.5 GlaxoSmithKline Plc Recent Developments
  7. 7.2 Beijing Tiantan Biological Products Co., Ltd.
  8. 7.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  9. 7.2.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  10. 7.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolio
  12. 7.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  13. 7.3 Beijing Minhai Biotechnology Co., Ltd
  14. 7.3.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  15. 7.3.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  16. 7.3.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolio
  18. 7.3.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  19. 7.4 Zydus Cadila Healthcare Limited
  20. 7.4.1 Zydus Cadila Healthcare Limited Company Information
  21. 7.4.2 Zydus Cadila Healthcare Limited Business Overview
  22. 7.4.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolio
  24. 7.4.5 Zydus Cadila Healthcare Limited Recent Developments
  25. 7.5 Sinovac Biotech Ltd.
  26. 7.5.1 Sinovac Biotech Ltd. Company Information
  27. 7.5.2 Sinovac Biotech Ltd. Business Overview
  28. 7.5.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sinovac Biotech Ltd. Mumps Drug Product Portfolio
  30. 7.5.5 Sinovac Biotech Ltd. Recent Developments
  31. 7.6 Prometheon Pharma, LLC
  32. 7.6.1 Prometheon Pharma, LLC Company Information
  33. 7.6.2 Prometheon Pharma, LLC Business Overview
  34. 7.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Prometheon Pharma, LLC Mumps Drug Product Portfolio
  36. 7.6.5 Prometheon Pharma, LLC Recent Developments
  37. 7.7 Organic Vaccines
  38. 7.7.1 Organic Vaccines Company Information
  39. 7.7.2 Organic Vaccines Business Overview
  40. 7.7.3 Organic Vaccines Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Organic Vaccines Mumps Drug Product Portfolio
  42. 7.7.5 Organic Vaccines Recent Developments
  43. 7.8 China National Pharmaceutical Group Corporation
  44. 7.8.1 China National Pharmaceutical Group Corporation Company Information
  45. 7.8.2 China National Pharmaceutical Group Corporation Business Overview
  46. 7.8.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolio
  48. 7.8.5 China National Pharmaceutical Group Corporation Recent Developments
8 North America
  1. 8.1 North America Mumps Drug Market Size by Type
  2. 8.1.1 North America Mumps Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Mumps Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Mumps Drug Price by Type (2021-2032)
  5. 8.2 North America Mumps Drug Market Size by Application
  6. 8.2.1 North America Mumps Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Mumps Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Mumps Drug Price by Application (2021-2032)
  9. 8.3 North America Mumps Drug Market Size by Country
  10. 8.3.1 North America Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mumps Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mumps Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mumps Drug Market Size by Type
  2. 9.1.1 Europe Mumps Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mumps Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Mumps Drug Price by Type (2021-2032)
  5. 9.2 Europe Mumps Drug Market Size by Application
  6. 9.2.1 Europe Mumps Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mumps Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Mumps Drug Price by Application (2021-2032)
  9. 9.3 Europe Mumps Drug Market Size by Country
  10. 9.3.1 Europe Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mumps Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mumps Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mumps Drug Market Size by Type
  2. 10.1.1 China Mumps Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Mumps Drug Sales by Type (2021-2032)
  4. 10.1.3 China Mumps Drug Price by Type (2021-2032)
  5. 10.2 China Mumps Drug Market Size by Application
  6. 10.2.1 China Mumps Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Mumps Drug Sales by Application (2021-2032)
  8. 10.2.3 China Mumps Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mumps Drug Market Size by Type
  2. 11.1.1 Asia Mumps Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mumps Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Mumps Drug Price by Type (2021-2032)
  5. 11.2 Asia Mumps Drug Market Size by Application
  6. 11.2.1 Asia Mumps Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mumps Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Mumps Drug Price by Application (2021-2032)
  9. 11.3 Asia Mumps Drug Market Size by Country
  10. 11.3.1 Asia Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mumps Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mumps Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mumps Drug Market Size by Type
  2. 12.1.1 SAMEA Mumps Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mumps Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mumps Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Mumps Drug Market Size by Application
  6. 12.2.1 SAMEA Mumps Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mumps Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mumps Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Mumps Drug Market Size by Country
  10. 12.3.1 SAMEA Mumps Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mumps Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mumps Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mumps Drug Value Chain Analysis
  2. 13.1.1 Mumps Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mumps Drug Production Mode & Process
  6. 13.2 Mumps Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mumps Drug Distributors
  9. 13.2.3 Mumps Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst